AC
BOLD

Athanor Capital’s Audentes Therapeutics, Inc BOLD Stock Holding History

Athanor Capital’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-30,000
Closed -$1.79M – 430
2019
Q4 		$1.79M Buy
+30,000
New +$1.13M 0.08% 118

Athanor Capital's BOLD Position: Q1 2020 in Review

Athanor Capital sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 30,000 shares — an estimated $1.79M sold.

Athanor Capital first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $1.79M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Athanor Capital reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Athanor Capital sold 30,000 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.79M.
  • Athanor Capital first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Athanor Capital's Audentes Therapeutics, Inc position peaked at $1.79M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Athanor Capital's 13F filing for Q1 2020, filed 14 May 2020.